• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Re­gen­eron wins ap­peals court or­ders back­ing halt on Eylea biosim­i­lars

4 months ago
Pharma
Law

FDA ap­proves Ax­some's acute mi­graine treat­ment af­ter 2022 re­jec­tion

4 months ago
Pharma
FDA+

Black­stone se­cures $1.6B so far for new life sci­ences fund tar­get­ed at $5B+

4 months ago
Financing

Hims is mak­ing its Su­per Bowl de­but with an ad that goes straight for phar­ma

4 months ago
Health Tech

Rentschler ex­its cell and gene busi­ness due to low de­mand, will pri­or­i­tize bi­o­log­ics

4 months ago
People
Manufacturing

Take­da scraps pro­grams as it rais­es full-year guid­ance 

4 months ago
Pharma

Bright Green bud­gets $3.5B for new builds; Eu­ro­pean Com­mis­sion opens bio­man­u­fac­tur­ing hub

4 months ago
Manufacturing

Car­go Ther­a­peu­tics cuts lead CAR-T pro­gram, 50% of staff

4 months ago
People
R&D

Iron­wood's lay­offs; Sh­iono­gi’s RSV pill suc­ceeds in Phase 2

4 months ago
News Briefing

Tec­ton­ic gets Phase 1b win in heart con­di­tion where Eli Lil­ly re­cent­ly failed

4 months ago
R&D

How De­fine Ven­tures thinks health tech star­tups will ex­it in 2025

4 months ago
Health Tech

Take­da CEO Christophe We­ber to re­tire in June 2026, Julie Kim to take over

4 months ago
People
Pharma

Mer­ck stops an­oth­er Win­re­vair study ear­ly based on pos­i­tive re­sults from ear­li­er PAH tri­al

4 months ago
R&D

Roche aims for de­risked deals and ruth­less port­fo­lio cuts in 2025

4 months ago
Deals
R&D

Sanofi is in the mar­ket for M&A, thanks to ‘strong’ bal­ance sheet

4 months ago
Deals
Pharma

In­hibikase shelves Parkin­son’s as­set af­ter Phase 2 flop

4 months ago
R&D

Ex­clu­sive: Fer­til­i­ty start­up to be­gin Phase 3 study of stem cell ther­a­py for IVF

4 months ago
R&D
FDA+

Te­va CEO says Auste­do can grow 'way be­yond' im­pact of IRA

4 months ago
Pharma

8VC, a tech and life sci­ences VC firm be­hind Al­tos Labs, eyes $1B fund

4 months ago
Financing
Startups

Lon­za looks to buy fa­cil­i­ties and tech to boost ser­vice of­fer­ings

4 months ago
Deals
Manufacturing

23andMe weighs a sale as cash dwin­dles

4 months ago
Financing
Health Tech

Curie.Bio has a new $340M fund; Lay­offs at Bench­ling, I-Mab

4 months ago
News Briefing

Trump ad­min­is­tra­tion makes first com­ments on how it will run IRA drug ne­go­ti­a­tions

4 months ago
Pharma
FDA+

Key GOP sen­a­tor is ‘strug­gling’ with Kennedy nom­i­na­tion over vac­cine an­swers

4 months ago
People
Pharma
First page Previous page 48495051525354 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times